bpc-157 randomized clinical trial humans Frontiers BPC-157 and Healing Peptides: Hype

The Harding lab work is real and interesting but is hypothesis-generating research, not clinical efficacy data

DAP BII sequentially releases Asp-Arg, Val-Tyr, Ile-His, Pro-Phe and His-Leu from the N terminus of angiotensin I to degrade it completely into dipeptides 10

Flightless I is a catabolic factor of chondrocytes that promotes hypertrophy and cartilage degeneration in osteoarthritis

These are essential elements of informed consent when prescribing compounded HRT

As a precautionary measure after reviewing different studies and considering multiple factors at play, including variability in absorption, daily losses, and reduced absorption rates at high intakes

doi: 10.1001/archsurg.1991.01410260101014